Cargando…
Spotlight on MuSK positive myasthenia gravis: clinical characteristics, treatment and outcomes
BACKGROUND: To investigate the clinical characteristics, treatments and outcomes of patients with myasthenia gravis with antibodies to muscle-specific tyrosine kinase (MuSK-MG). METHODS: We retrospectively reviewed the cases of 21 patients with confirmed MuSK-MG between January 2012 and January 2020...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895578/ https://www.ncbi.nlm.nih.gov/pubmed/35246057 http://dx.doi.org/10.1186/s12883-022-02593-6 |